PATENT CLAIM ANALYSIS

Application Number: 15741570
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["540", "568000"]

Abstract:
The present invention relates to a method for the stereo-selective production of pentostatin comprising an enzymatic transglycosylation reaction between 6,7-dihydroimidazo-[4,5-d]-[1,3]diazepin-8(3H)-one and a 2′-deoxyribonucleoside, followed by an ruthenium-catalyzed asymmetric transfer hydrogenation.

Claim (Index 11):
The method of  claim 2 , wherein the 2-deoxy-ribonucleoside is used in an amount of 1.5 to 10 molar equivalents of the amount of 6,7-dihydroimidazo[4,5-d]-[1,3]diazepin-8(3H)-one.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.1
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12223746', '11873202', '10865719', '12489716', '11742626']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6515200954899261
- 35 USC 102 Novelty (BERT): 0.4858833918999564
- Combined Prediction Score: 0.6349564251309291
- Mean Citation Score: 176.574106
- Max Citation Score: 186.74408
- Similarity Product: 145.69179934669015

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test